NASDAQ:ORIC | Insider Transactions — Page 2 | Oric Pharmaceuticals, Inc.

ORIC Insider Transactions — Page 2

149 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–149; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
GORDON CARL LDirector2021-03-30Sale27,869.0$23.93
ORBIMED ADVISORS LLCDirector2021-03-30Sale27,869.0$23.93
OrbiMed Capital GP VI LLCDirector2021-03-30Sale27,869.0$23.93
GORDON CARL LDirector2021-03-29Sale75,555.0$23.31
ORBIMED ADVISORS LLCDirector2021-03-29Sale75,555.0$23.31
OrbiMed Capital GP VI LLCDirector2021-03-29Sale75,555.0$23.31
ORBIMED ADVISORS LLCDirector2021-03-26Sale27,816.0$23.88
OrbiMed Capital GP VI LLCDirector2021-03-26Sale27,816.0$23.88
GORDON CARL LDirector2021-03-26Sale27,816.0$23.88
ORBIMED ADVISORS LLCDirector2021-03-25Sale51,523.0$24.7
OrbiMed Capital GP VI LLCDirector2021-03-25Sale51,523.0$24.7
GORDON CARL LDirector2021-03-25Sale51,523.0$24.7
ORBIMED ADVISORS LLCDirector2021-03-24Sale32,959.0$24.8
OrbiMed Capital GP VI LLCDirector2021-03-24Sale32,959.0$24.8
GORDON CARL LDirector2021-03-24Sale32,959.0$24.8
GORDON CARL LDirector2021-03-23Sale3,992.0$24.32
ORBIMED ADVISORS LLCDirector2021-03-23Sale3,992.0$24.32
OrbiMed Capital GP VI LLCDirector2021-03-23Sale3,992.0$24.32
GORDON CARL LDirector2021-03-22Sale7,673.0$26.47
ORBIMED ADVISORS LLCDirector2021-03-22Sale7,673.0$26.47
OrbiMed Capital GP VI LLCDirector2021-03-22Sale7,673.0$26.47
GORDON CARL LDirector2021-03-19Sale21,275.0$26.47
ORBIMED ADVISORS LLCDirector2021-03-19Sale21,275.0$26.47
OrbiMed Capital GP VI LLCDirector2021-03-19Sale21,275.0$26.47
ORBIMED ADVISORS LLCDirector2021-03-18Sale6,059.0$28.03
OrbiMed Capital GP VI LLCDirector2021-03-18Sale6,059.0$28.03
GORDON CARL LDirector2021-03-18Sale6,059.0$28.03
ORBIMED ADVISORS LLCDirector2021-03-17Sale18,790.0$28.43
OrbiMed Capital GP VI LLCDirector2021-03-17Sale18,790.0$28.43
GORDON CARL LDirector2021-03-17Sale18,790.0$28.43
ORBIMED ADVISORS LLCDirector2021-03-16Sale41,353.0$27.72
OrbiMed Capital GP VI LLCDirector2021-03-16Sale41,353.0$27.72
GORDON CARL LDirector2021-03-16Sale41,353.0$27.72
ORBIMED ADVISORS LLCDirector2021-03-15Sale89,210.0$29.14
OrbiMed Capital GP VI LLCDirector2021-03-15Sale89,210.0$29.14
GORDON CARL LDirector2021-03-15Sale89,210.0$29.14
ORBIMED ADVISORS LLCDirector2021-03-12Sale90,521.0$30.29
OrbiMed Capital GP VI LLCDirector2021-03-12Sale90,521.0$30.29
GORDON CARL LDirector2021-03-12Sale90,521.0$30.29
ORBIMED ADVISORS LLCDirector2021-03-11Sale58,551.0$33.04
OrbiMed Capital GP VI LLCDirector2021-03-11Sale58,551.0$33.04
GORDON CARL LDirector2021-03-11Sale58,551.0$33.04
GUTHART LEOTenPercentOwner2020-11-04Sale2,268,750.0
Topspin Fund L.P.TenPercentOwner2020-11-04Sale2,268,750.0
LG Management, LLCTenPercentOwner2020-11-04Sale2,268,750.0
Topspin Biotech Fund II, L.P.TenPercentOwner2020-11-04Sale2,268,750.0
ORBIMED ADVISORS LLCDirector,TenPercentOwner2020-04-24Purchase281,250.0$16.0
OrbiMed Capital GP VI LLCDirector,TenPercentOwner2020-04-24Purchase281,250.0$16.0
GORDON CARL LDirector,TenPercentOwner2020-04-24Purchase281,250.0$16.0